News
23h
Sportschosun on MSNDeveloping AI technology to determine the cause of left ventricular hypertrophy only with echocardio...A research team led by Yoon Yeon-yi, a professor of circulatory technology at Seoul National University Bundang Hospital, is ...
Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
11h
News-Medical.Net on MSNDual treatment strategy offers survival advantage for patients with severe heart diseaseAortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the ...
Hadassah doctors performed the country’s first-ever complete artificial heart transplant on a 63-year-old patient, offering ...
The following is a summary of “Apelinergic System in the Left Ventricle Adverse Remodeling After Myocardial Infarction: A ...
EBR Systems Inc. raised AU$55.9 million (US$36 million) to commercialize its Wise cardiac resynchronization therapy system ...
A 46-year-old woman with type 1 myotonic dystrophy (DM1) presented to the emergency department with dyspnea and palpitations.
The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results